Australia's most trusted
source of pharma news
Posted 3 October 2024 AM
Rare Cancers Australia (RCA) has entered an implementation partnership agreement with Cancer Australia to help deliver critical programs through the Australian Cancer Plan, which will support better outcomes and experiences for people with rare cancers.
The 10-year Plan, launched in late 2023, is Australia's first national cancer plan to improve outcomes and address inequities for those living with cancer in Australia. Backed by $750 million in funding, its six strategic objectives for the foundation for transforming cancer services and outcomes.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.